Debbie Carter
Directeur en chef des Investissements chez Hoverink Capital Management LLC
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Cyrus Sajna | M | 42 |
Hoverink Capital Management LLC
 Hoverink Capital Management LLC Investment ManagersFinance Hoverink Capital Management LLC (Hoverink Capital Management) is a private equity firm founded in Founded in 2015. The firm is headquartered in Grapevine,Texas. | 9 ans |
| Davidra Nicole Sajna | F | - |
Hoverink Biotechnologies, Inc.
 Hoverink Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Hoverink Biotechnologies, Inc. operates as a biopharmaceutical company, which discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and oncological diseases and disorders. Its product candidate includes Ladavru, which is developed for treating cirrhosis ascites, cirrhosis, AIDS, and chronic pain, nausea and discomfort associated with chemotherapy. The company was founded by Cyrus Sajna on July 2, 2013 and is headquartered in Los Angeles, CA. | 9 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| James Cassidy | M | 88 |
Hoverink Biotechnologies, Inc.
Hoverink Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Hoverink Biotechnologies, Inc. operates as a biopharmaceutical company, which discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and oncological diseases and disorders. Its product candidate includes Ladavru, which is developed for treating cirrhosis ascites, cirrhosis, AIDS, and chronic pain, nausea and discomfort associated with chemotherapy. The company was founded by Cyrus Sajna on July 2, 2013 and is headquartered in Los Angeles, CA. | - |
| James McKillop | M | 64 |
Hoverink Biotechnologies, Inc.
Hoverink Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Hoverink Biotechnologies, Inc. operates as a biopharmaceutical company, which discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and oncological diseases and disorders. Its product candidate includes Ladavru, which is developed for treating cirrhosis ascites, cirrhosis, AIDS, and chronic pain, nausea and discomfort associated with chemotherapy. The company was founded by Cyrus Sajna on July 2, 2013 and is headquartered in Los Angeles, CA. | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 4 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Debbie Carter
- Réseau Personnel
